Targeted validation: validating clinical prediction models in their intended population and setting

HIGHLIGHTS

• who: Matthew Sperrin from the , MACS was developed using data from a hospital in Manchester, and validated using data from other hospitals in Manchester [13]Hence the original development and validation results match the intended use. If, however, we wished to use, MACS in London, UK have published the Article: Targeted validation: validating clinical prediction models in their intended population and setting, in the Journal: (JOURNAL)
• what: The aim of this paper is to describe why it is necessary to validate a CPM in a population and setting that represents each intended target population and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.